Clinical Trials Browser

Unknown × EGFR Positive Non-small Cell Lung Cancer × Clear all

NCT06208033 2024-01-17

SMET12 and Toripalimab Combined Chemotherapy in Patients With EGFR Positive Advanced Non-small Cell Lung Cancer (NSCLC)

Phase EARLY_PHASE1 Unknown

EGFR Positive Non-small Cell Lung Cancer

NCT03126799 2022-04-06

AvaTa

Phase 2 Unknown

EGFR Positive Non-small Cell Lung Cancer

NCT03382795 2021-07-15

Retreatment With Epidermal Growth Factor Receptor(EGFR) Tyrosine Kinase Inhibitor in EGFR Mutation Positive Patients

Phase 2 Unknown

EGFR Positive Non-small Cell Lung Cancer